Inhibikase Therapeutics shares owned by Redmond Asset Management
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Redmond Asset Management
from 13F filings
Historical chart of Redmond Asset Management investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Redmond Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Redmond Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $25k | 20k | 1.27 |
| 2023-09-30 | $29k | 21k | 1.39 |
| 2023-06-30 | $76k | 21k | 3.61 |